Daxor Co. (NASDAQ:DXR) Short Interest Up 39.6% in September

Daxor Co. (NASDAQ:DXR) was the target of a significant increase in short interest during the month of September. As of September 15th, there was short interest totalling 14,800 shares, an increase of 39.6% from the August 31st total of 10,600 shares. Approximately 0.7% of the shares of the company are sold short. Based on an average daily volume of 4,000 shares, the short-interest ratio is currently 3.7 days.

Daxor Stock Down 2.3 %

DXR stock traded down $0.21 during mid-day trading on Friday, reaching $8.89. 21,291 shares of the company traded hands, compared to its average volume of 3,723. The company has a fifty day moving average price of $8.90 and a 200-day moving average price of $9.09. Daxor has a 52-week low of $7.11 and a 52-week high of $10.04.

Wall Street Analyst Weigh In

Separately, Ascendiant Capital Markets raised their price target on shares of Daxor from $24.50 to $24.75 and gave the stock a “buy” rating in a research note on Monday, September 9th.

Daxor Company Profile

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.